STORY · PRODUKTER_
OpenEvidence reaches 12 billion dollar valuation with massive clinical adoption
AI tool OpenEvidence, designed to help doctors with diagnosis and treatment, has been valued at 12 billion dollars—a 12x increase from the previous year. The platform is already used by 40 percent of American physicians and generates over 100 million dollars in annual revenue.
WHY IT MATTERS
This demonstrates how AI solutions for professional domains dominate when they achieve critical mass of actual users and economic impact. It signals a shift from AI as experiment to AI as an integrated part of clinical practice.
SOURCES
MACHINE-GENERATED SUMMARY This summary is written by machine from the sources below. We sort and explain — but we are a way into the field, not the final word. Check the source when something matters to you.